<PAGE> 1
==============================================================================
- ------------------------------------------------------------------------------
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark One)
|X| QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934.
For the quarterly period ended June 30, 1997
OR
|_| TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from ____________ to ____________
Commission File Number: 0-21802
______________________
N-VIRO INTERNATIONAL CORPORATION
(Exact name of registrant as specified in its charter)
Delaware 34-1741211
(State or other jurisdiction of (IRS Employer Identification No.)
incorporation or organization)
3450 W. Central Avenue, Suite 328
Toledo, Ohio 43606
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (419) 535-6374
______________________
Indicate by check mark whether the registrant (1) has filed all
reports required to be filed by Section 13 or 15(d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period that
the registrant was required to file such reports), and (2) has been subject to
the filing requirements for at least the past 90 days. Yes X No .
--- ---
As of June 30, 1997, 2,230,750 shares of N-Viro International
Corporation $ .01 par value common stock were outstanding.
- ------------------------------------------------------------------------------
==============================================================================
-1-
<PAGE> 2
<TABLE>
<CAPTION>
PART I - FINANCIAL INFORMATION
Item 1. Financial Statements
N-VIRO INTERNATIONAL CORPORATION
CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)
Three Months Ended June 30 Six Months Ended June 30
--------------------------------------- --------------------------------------
1997 1996 1997 1996
------------------ ------------------ ------------------ ------------------
<S> <C> <C> <C> <C>
Revenues $ 1,081,293 $ 995,703 $ 2,150,159 $ 1,949,275
Cost of revenues 434,983 409,109 915,914 819,721
------------------ ------------------ ------------------ ------------------
Gross profit 646,310 586,594 1,234,245 1,129,554
Selling, general & admin. expenses 437,849 552,848 868,077 1,051,765
------------------ ------------------ ------------------ ------------------
Operating income 208,461 33,746 366,168 77,789
Other income (expense):
Interest income (expense), net (8,302) 2,643 (17,952) 4,957
Equity in gains of joint ventures 0 (1,125) 18,540 21,535
Other income (loss) 9,375 (3,724) 6,678 31,774
------------------ ------------------ ------------------ ------------------
Income before income taxes 209,534 31,540 373,434 136,055
Income taxes - - - -
------------------ ------------------ ------------------ ------------------
Net income $ 209,534 $ 31,540 $ 373,434 $ 136,055
================== ================== ================== ==================
Net income per share $ 0.10 $ 0.02 $ 0.18 $ 0.07
================== ================== ================== ==================
Weighted ave. common shares outstanding 2,037,000 2,037,000 2,037,000 2,037,000
================== ================== ================== ==================
</TABLE>
See Notes to Consolidated Financial Statements
-2-
<PAGE> 3
<TABLE>
<CAPTION>
N-VIRO INTERNATIONAL CORPORATION
CONSOLIDATED BALANCE SHEETS
June 30, December 31,
1997 1996
ASSETS (Unaudited) (Audited)
----------------------- -----------------------
<S> <C> <C>
Current assets
Cash and cash equivalents $ 79,072 $ 282,115
Securities available-for-sale 1,401 1,401
Trade receivables 1,107,166 788,628
Other receivables 100,584 113,544
Assets held for sale 793,139 780,108
Prepaid expenses and other assets 312,772 225,597
----------------------- -----------------------
Total Current assets 2,394,134 2,191,393
Property and equipment 593,677 621,558
Investment in Joint Ventures 924,281 919,352
Intangibles and Other assets 442,475 434,634
----------------------- -----------------------
TOTAL ASSETS $ 4,354,567 $ 4,166,937
======================= =======================
LIABILITIES & STOCKHOLDERS' EQUITY
Current liabilities
Current maturities of long-term debt $ 645,283 $ 911,706
Accounts payable 1,239,476 1,306,862
Accrued expenses 196,568 258,779
----------------------- -----------------------
Total Current liabilities 2,081,327 2,477,347
----------------------- -----------------------
Long-Term Debt, less current maturities 76,747 276,031
----------------------- -----------------------
Stockholders' Equity
Common stock, $.01 par value; authorized
45,000,000 shares; issued 1997 2,230,750
and 1996 2,094,250 shares 22,308 20,943
Additional paid-in capital 12,456,591 12,048,455
Retained earnings (deficit) (9,664,429) (10,037,862)
----------------------- -----------------------
2,814,470 2,031,536
Less treasury stock, at cost, 57,250 shares 617,977 617,977
----------------------- -----------------------
2,196,493 1,413,559
----------------------- -----------------------
TOTAL LIABILITIES & STOCKHOLDERS' EQUITY $ 4,354,567 $ 4,166,937
======================= =======================
</TABLE>
See Notes to Consolidated Financial Statements
-3-
<PAGE> 4
<TABLE>
<CAPTION>
N-VIRO INTERNATIONAL CORPORATION
CONSOLIDATED STATEMENTS OF CASH FLOWS
(UNAUDITED)
Six Months Ended
June 30,
-------------------------------------------
1997 1996
-------------------- -------------------
<S> <C> <C>
NET CASH PROVIDED BY OPERATING ACTIVITIES $ 316,691 $ 29,885
CASH FLOWS FROM INVESTING ACTIVITIES:
Proceeds from joint venture --- 250,000
Proceeds from sale of property and equipment 4,665 67,511
Expenditures for property and equipment (32,137) (110,648)
Expenditures for intangibles and other assets (23,879) (15,375)
-------------------- -------------------
NET CASH PROVIDED (USED) BY INVESTING ACTIVITIES (51,351) 307,817
CASH FLOWS FROM FINANCING ACTIVITIES
Repayments of long-term debt (555,883) (458,282)
Issuance of notes payable --- 100,000
Net borrowings on revolving credit agreement 87,500 ---
-------------------- -------------------
NET CASH USED BY FINANCING ACTIVITIES (468,383) (358,282)
-------------------- -------------------
NET DECREASE IN CASH (203,043) (136,909)
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD 282,115 223,942
-------------------- -------------------
CASH AND CASH EQUIVALENTS AT END OF PERIOD $ 79,072 $ 87,033
==================== ===================
</TABLE>
See Notes to Consolidated Financial Statements
-4-
<PAGE> 5
N-VIRO INTERNATIONAL CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
1. ORGANIZATION AND BASIS OF PRESENTATION
The accompanying consolidated financial statements of N-Viro
International Corporation (the Company) are unaudited but, in management's
opinion, reflect all adjustments (including only normal recurring accruals)
necessary to present fairly such information for the period and at the dates
indicated. The results of operations for the six months ended June 30, 1997
may not be indicative of the results of operations for the year ended December
31, 1997. Since the accompanying consolidated financial statements have been
prepared in accordance with Article 10 of Regulation S-X, they do not contain
all information and footnotes normally contained in annual consolidated
financial statements; accordingly, they should be read in conjunction with the
consolidated and combined financial statements and notes thereto appearing in
the Company's Form 10-K for the period ending December 31, 1996.
N-Viro International Corporation was incorporated in April 1993 and is
the successor to N-Viro Energy Systems, Ltd. (the Partnership) and five
Company Agents. The Company Agents together with the Partnership are the
Company Entities.
On October 19, 1993, the Partnership contributed to the Company all of
its assets (except certain marketable securities and accounts receivable from
certain related parties), subject to all liabilities (except certain retained
liabilities), and the shareholders of the Company Agents contributed to the
Company all of the outstanding capital stock of such entities in exchange for
a total of six million shares of common stock of the Company and organization
notes totaling $5,221,709 (such transactions are collectively referred to as
the Organization). The Organization notes were repaid out of the proceeds from
an initial public offering of two million shares of N-Viro International
Corporation common stock. A total of 2,112,000 new shares were issued in the
IPO, including shares issued in the partial exercise by the Underwriters of an
over-allotment option.
The financial statements are consolidated as of June 30, 1997 and
December 31, 1996 for the Company. Adjustments have been made to eliminate all
intercompany transactions.
The Company's consolidated financial statements have been presented on
the basis that it is a going concern. Such basis assumes the realization of
assets and the satisfaction of liabilities, each in the normal course of
business. The Company has generated positive cash flows from operating
activities in 1997. However, the amount of cash and investments available at
June 30, 1997 are not sufficient to finance the current level of operations and
satisfy other cash requirements through 1997 and into 1998. Consequently, the
Company's ability to meet its current and future obligations is primarily
dependent upon its ability to continue profitable operations and obtain
additional debt financing. The Company is negotiating to obtain additional
short-term debt financing which, in management's opinion, would provide adequate
cash flow to finance the Company's cash requirements. The satisfactory
completion of those plans are the Company's principal means of providing
sufficient cash flows to meet 1997 obligations.
2. RELATED PARTY TRANSACTIONS
-5-
<PAGE> 6
The Company recognized an expense to Mr. Bobby B. Carroll, a Director
of the Company and a former shareholder of Tennessee-Carolina N-Viro, Inc., of
$60,000 for the six months ended June 30, 1997, and $30,000 for the six months
ended June 30, 1996 under a contract arrangement signed in 1993 for consulting
services. The Company granted Mr. Carroll a security interest in all present
and future receivables and contract rights from licenses in the states of
Tennessee, North Carolina and South Carolina pursuant to the contract
agreement.
In June of 1997, the Company reached agreements with three trade
creditors to eliminate, in the aggregate, $259,500 of the Company's short-term
debt in exchange for the Company's issuance and delivery to such creditors, in
the aggregate, 86,500 shares of Common Stock. All three trade creditors are
current members of the Board of Directors of the Company, J. Patrick Nicholson,
Bobby Carroll and Frederick Kurtz. Additionally, Mr. Nicholson is the Chairman
of the Board, Chief Executive Officer and President of the Company. The number
of shares of Common Stock issued to, and the corresponding amount of short-term
debt forgiven by Mr. Nicholson, Mr. Carroll and Mr. Kurtz is set forth in the
table below: All such shares of Common Stock were issued and delivered to the
Company's creditors pursuant to appropriate exemptions from registration under
the Securities Act and state securities laws. All of the exchanges were
evidenced by written Share Exchange Agreements between the Company and each of
the creditors. Copies of such Share Exchange Agreements were filed as Exhibits
to the Company's Form 8-K filed on July 18, 1997 which has been incorporated
herein by reference.
<TABLE>
<CAPTION>
No of Shares Issued in
Creditor Amount of Cancelled Debt Exchange
- -------- ------------------------ ----------------------
<S> <C> <C>
J. Patrick Nicholson $ 48,000 16,000
Bobby Carroll $150,000 50,000
Frederick Kurtz $ 61,500 20,500
</TABLE>
In addition to the share exchanges described above, the Company, in
June of 1997, also reached agreement with N-Viro Energy Systems, Ltd. an Ohio
limited partnership ("NVESL") and the holder of 45% of the issued and
outstanding share of the Common Stock to cancel $150,000 of the Company's
short-term debt to NVESL in exchange for the Company's issuance and delivery to
NVESL of 50,000 shares of Common Stock. At the time of this agreement, the
Company's total indebtedness to NVESL was $176,500. Such indebtedness was
evidences by three promissory notes in the aggregate amount of $191,500. In
exchange for the cancellation of the three original promissory notes, the
Company agreed to issue and deliver to NVESL (i) 50,000 shares of Common Stock
and (ii) a promissory note in the amount of $26,500. The shares of Common Stock
issued and delivered to NVESL were issued and delivered pursuant to applicable
exemptions from registration under the Securities Act and state securities
laws. Further, this exchange was evidenced by a written Share Exchange
Agreement which was filed by the Company as an Exhibit to the Company's Form
8-K filed on July 18, 1997.
3. CONTINGENCIES
The Company leases office space under an agreement which requires
monthly payments of $4,664. The lease expires in December 1997. The total
minimum rental commitment at June 30, 1997 is $28,000. The total rental
expense included in the statements of operations for each of the periods ended
June 30, 1997 and 1996 is approximately $28,000.
During 1994, the Company reacquired territory rights to several states
from a former agent. In consideration for the rights, the Company paid
$200,000 in cash and issued 66,250 shares of unregistered common stock with a
designated value of $324,625. In the event the former agent elects to sell all
these shares at the earliest date possible, the Company has guaranteed the
former agent $6 per share. If the former agent receives in excess of $10 per
share, the Company will receive 50% of the excess amount.
The Company is involved in legal proceedings and subject to claims
which have arisen in the ordinary course of business. These actions, when
concluded and determined, will not, in the opinion of management, have a
material adverse effect upon the financial position of the Company.
Item 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
AND RESULTS OF OPERATIONS
OVERVIEW
N-Viro International Corporation was incorporated in April, 1993, and
became a public company on October 12, 1993. The Company's business strategy
is to market the N-Viro Process that produces an "exceptional quality" sludge
product, as defined in the Section 503 Sludge Regulations under the Clean
Water Act of 1987, with multiple commercial uses. To date, the Company's
revenues primarily have been derived from the licensing of the N-Viro Process
to treat and recycle wastewater sludge generated by municipal wastewater
treatment plants and from the sale to licensees of the alkaline admixture used
in the N-Viro Process. The Company has also operated N-Viro facilities for
third parties on a start-up basis and currently operates one N-Viro facility
on a contract management basis. There are currently 37 N-Viro facilities
operating throughout the world using the N-Viro Process. The Company estimates
that these operating N-Viro facilities are treating and recycling sludge at an
annualized rate of approximately 150,000 dry tons per year.
Total revenues of $1,081,000 for the quarter ended June 30, 1997
compared to $996,000 for the same period of 1996. The increase in revenue is
due primarily to an increase in license fees. The Company increased its cost
of revenues from the same period of 1996 due to the increase in management fee
revenue, with the gross profit percentage increasing only slightly. Selling,
general and administrative costs also continued to decrease from the same
period of 1996. These changes resulted in a net profit of $210,000 for the
quarter ended June 30, 1997 compared to a net profit of $32,000 for the
quarter ended June 30, 1996.
-6-
<PAGE> 7
The Company anticipates that its development of a network of
marketing representatives and regional partnerships will more than offset the
Company's reduced staffing in generating new sales revenue.
COMPARISON OF THREE MONTHS ENDED JUNE 30, 1997 WITH THREE MONTHS ENDED JUNE 30,
1996
Overall revenue increased $86,000, or 9% to $1,081,000 for the three
months ended June 30, 1997 from $996,000 for the three months ended June 30,
1996. The net increase in revenue was due primarily to the following:
a) Licensing of the N-Viro process, including territory fees, earned
the Company $165,000 for the quarter, an increase of $65,000 over the same
period in 1996;
b) The Company's processing revenue, including facility management
revenue, posted a net increase of $39,000 over the same period ended June 30,
1996;
c) Sales of alkaline admixture increased $12,000 over the same period
ended June 30, 1996;
d) The elimination in 1997 of $30,000 revenue from the Company's
wholly owned subsidiary, BioCheck Laboratories, Inc. ("BioCheck"), which was
sold in April, 1996.
Gross profit increased $60,000, or 10%, to $646,000 for the three
months ended June 30, 1997 from $587,000 for the three months ended June 30,
1996, primarily from the net increase in license and territory fees. The gross
profit margin increased slightly to 60% from 59% for the same six month
comparison.
Selling, general and administrative expenses decreased $115,000, or
21%, to $438,000 for the three months ended June 30, 1997 from $553,000 for
the three months ended June 30, 1996. The decrease was primarily from reduced
personnel and related costs.
As a result of the foregoing factors, the Company recorded operating
income of $208,000 for the three months ended June 30, 1997 compared to
operating income of $34,000 for the three months ended June 30, 1996.
The Company has not fully recognized the tax benefit of the losses
incurred in prior periods and accordingly, the effective tax rate for the
period was zero.
COMPARISON OF SIX MONTHS ENDED JUNE 30, 1997 WITH SIX MONTHS ENDED JUNE 30, 1996
Overall revenue increased $201,000, or 10% to $2,150,000 for the six
months ended June 30, 1997 from $1,949,000 for the six months ended June 30,
1996. The net increase in revenue was due primarily to the following:
a) Licensing of the N-Viro process, including territory fees, earned
the Company $245,000 for the year, an increase of $145,000 over the same
period in 1996;
b) The Company's processing revenue, including facility management
revenue, posted a net increase of $40,000 over the same period ended June 30,
1996;
c) Sales of alkaline admixture increased $74,000 over the same period
ended June 30, 1996;
-7-
<PAGE> 8
d) The elimination in 1997 of $55,000 revenue from the Company's
wholly owned subsidiary, BioCheck Laboratories, Inc. ("BioCheck"), which was
sold in April, 1996.
Gross profit increased $105,000, or 9%, to $1,234,000 for the six
months ended June 30, 1997 from $1,130,000 for the six months ended June 30,
1996, primarily from the elimination of low gross profits associated with
BioCheck, and the net increase in license and territory fees. The gross profit
margin decreased slightly to 57% from 58% for the same six month comparison.
Selling, general and administrative expenses decreased $184,000, or
17%, to $868,000 for the six months ended June 30, 1997 from $1,052,000 for
the six months ended June 30, 1996. The decrease was primarily from reduced
personnel and related costs.
As a result of the foregoing factors, the Company recorded operating
income of $366,000 for the six months ended June 30, 1997 compared to
operating income of $78,000 for the six months ended June 30, 1996.
The Company has not fully recognized the tax benefit of the losses
incurred in prior periods and accordingly, the effective tax rate for the
period was zero.
LIQUIDITY AND CAPITAL RESOURCES
In its February 26, 1997 Report of Independent Auditors to the
Company's Board of Directors, the Company's auditors raise the issue of the
Company's ability to continue as a "going concern", in light of the Company's
current financial position.
The Company had working capital of $313,000 at June 30, 1997, compared
to a deficit of ($286,000) at December 31, 1996. Current assets at June 30, 1997
included cash and investments of $80,000, which is a decrease of $203,000 from
December 31, 1996. The increase in working capital was principally due to the
restructuring of debt to equity and the operating income for the period.
Much of the Company's available funds have been used to reduce its
litigation settlement obligation to Frank Manchak, Jr. that originated in
1995. The Company paid Mr. Manchak a total of $290,000 in the first six months
of 1997.
At June 30, 1997, the Company had a balance due Mr. Manchak of
$410,000. On July 18, 1997, the Company made an additional payment to Mr.
Manchak of $30,000. Also on July 18, 1997, the Company and Mr. Manchak entered
into a Second Amendment to the original Settlement Agreement (the "Second
Amendment") between the parties with respect to that certain lawsuit entitled
FRANK MANCHAK, JR. V. N-VIRO ENERGY SYSTEMS, LTD. that was filed by Mr.
Manchak in the United States District Court for the Central District of
California, Case No. CV-93-3042-ABC.
Pursuant to the terms of the Second Amendment, the Company issued
250,000 shares (the "Shares") of the Company's voting common stock, with par
value of $.01 per share (the "Common Stock") as well as an option to purchase
an additional 100,000 shares of Common Stock, at a purchase price of $2.50 per
share. The Second Amendment further provides that the Company's remaining
obligation to Mr. Manchak in the amount of $380,000 will be due and payable in
full on November 15, 1997 without interest. The amount of this obligation,
however, will be reduced if Mr. Manchak sells any of the Shares prior to
November 1, 1997 and may be further reduced by certain payments that may be
made to Mr. Manchak by or on behalf of the Company prior to November 15, 1997,
all as more particularly described in the Second Amendment. The Company made
one such payment, in the amount of $60,000 to Mr. Manchak on or about August
1, 1997. This payment reduced the amount of the Company's remaining obligation
to Mr. Manchak
-8-
<PAGE> 9
to $320,000. The Second Amendment was filed with the Securities and Exchange
Commission as an exhibit to the Company's Current Report on Form 8-K dated
July 18, 1997 which is incorporated herein by reference.
Under the terms of the Second Amendment, prior to November 1, 1997,
Mr. Manchak may, but is not required to, sell Shares. Of the 250,000 shares of
Common Stock issued to Mr. Manchak under the Second Amendment, 100,000 shares
are being held in escrow by Shumaker, Loop & Kendrick, LLP, special counsel to
the Company (the "Escrow Agent"). The terms of the escrow are described in the
paragraphs below.
The number of shares of Common Stock that may be sold by Mr. Manchak
and the aggregate amount of proceeds from such sales that Mr. Manchak may
receive on a monthly basis are subject to certain limitations set forth in the
Second Amendment. These limitations preclude Mr. Manchak from selling more
than 45,000 shares of Common Stock during the months of July, August and
September and 55,000 shares of Common Stock in October of 1997. Mr. Manchak
did not sell any shares of Common Stock in July of 1997. The number of shares
of Common Stock that Mr. Manchak may sell on a monthly basis is limited
further by a provision in the Second Amendment to Settlement Agreement
limiting the aggregate amount of proceeds that he may receive from his sales
of Common Stock to $90,000 per month during the months of July, August and
September and $110,000 during the month of October. Once Mr. Manchak realizes
an amount equal to or greater than the proceeds limitation in any given month,
he is required to refrain from making any additional sales of shares of Common
Stock during such months.
All sums received by Mr. Manchak as a result of his sale of the
Shares, reduced by any transaction costs, such as broker's fees and
commissions incurred by him in the course of such sales, will reduce the
aggregate amount of the Company's remaining obligation to Mr. Manchak on a
dollar for dollar basis. As an inducement to Mr. Manchak to enter into the
Second Amendment, the Company has guaranteed that he will receive at least
$60,000 per month during the months of July, August, September and October
either from (x) his sales of the Shares, (y) through supplemental payments by
the Company or, (z) the redemption of some or all of the Shares by the
Company. Any such supplemental payments by the Company as well as any proceeds
from the Company's redemption of Shares will reduce, on a dollar for dollar
basis, the amount of the Company's remaining obligation to Mr. Manchak.
On or about October 1, 1997, based solely upon information provided
by Mr. Manchak and reviewed by the Company, the Escrow Agent will calculate
(i) the amount of the Company's remaining obligation to Mr. Manchak as at the
close of business on September 30, 1997 (the Remaining Obligation") and (ii)
the number of Shares held by Mr. Manchak as at the close of business on
September 30, 1997 (the "Remaining Shares"). After determining the amount of
the Remaining Obligation and the number of Remaining Shares, the Escrow Agent
shall multiply the number of Remaining Shares by two and subtract such number
of dollars from the amount of the Remaining Obligation to calculate the "Share
Deficit Amount". Finally, the Escrow Agent shall divide the Share Deficit
Amount by two and shall deliver to Mr. Manchak such number of shares of Common
Stock from the shares of Common Stock held in escrow. The remaining shares of
escrowed Common Stock, if any, shall be returned to the Company and retired.
In addition to 100,000 Shares, the Company also has agreed to place
$100,000 in escrow to meet certain of its contingent obligations to Mr.
Manchak pursuant to the terms of the Second Amendment. This $100,000 is to be
transferred by the Company to the Escrow Agent on August 15, 1997. Until such
time as the funds in escrow are exhausted, all payments required to be made by
the Company to Mr. Manchak pursuant to the terms of the Second Amendment shall
be made by the Escrow Agent from the funds held in escrow. After the funds
held in escrow are exhausted, and prior to August 15, 1997, payments shall be
made directly by the Company.
-9-
<PAGE> 10
At the Company's option it may satisfy the Share Deficit Amount
through the Escrow Agent's delivery to Mr. Manchak of a cash payment in an
amount equal to the Share Deficit Amount. On November 15, 1997, after
satisfaction of the Company's obligations to Mr. Manchak, any remaining funds
held in escrow shall be distributed to the Company.
On November 15, 1997, the remaining portion of the Company's
obligation to Mr. Manchak, if any, shall become due and payable. Under the
terms of the Second Amendment, the Company will satisfy any remaining portion
of the Company's obligation by redeeming, at a price of $2.00 per share, such
number of the Shares held by Mr. Manchak at such time as is necessary such
that the aggregate amount of funds received by Mr. Manchak as a result of his
sales of the Shares, exclusive of any transaction costs, such as broker's fees
and commissions, plus any cash payments received by him from the Company or
the Escrow Agent pursuant to the terms of the Second Amendment shall equal
$410,000. Mr. Manchak is under no obligation to sell any of the Shares to the
Company on November 15, 1997. However, any such Shares that Mr. Manchak
decides to retain on such date shall reduce the amount of the Company's
obligation to him by the sum of $2.00 per share.
The option granted to Mr. Manchak with respect to the purchase of an
additional 100,000 shares of Common Stock at a purchase price of $2.50 per
share shall become exercisable on November 15, 1997 and shall be exercisable
for a period of up to sixty days following such date. Pursuant to the terms of
the Second Amendment and the option, Mr. Manchak has the right to resell all
or a portion of the shares acquired pursuant to the terms of the option back
to the Company at a price of $3.00 per share at any time during the two
business days immediately following the date of the exercise of the option.
Mr. Manchak forfeits this right, however, in the event that he sells any of
the shares acquired upon exercise of the option in a public offering pursuant
to an effective registration statement under the Securities Act of 1933 and
the rules and regulations promulgated thereunder, as amended from time to
time. Prior to exercising the option, Mr. Manchak also has the right, in his
sole and absolute discretion, to require the Company to repurchase all or a
portion of the 100,000 shares of Common Stock covered by the option by paying
Mr. Manchak an amount equal to $.50 per share multiplied by the number of
shares of Common Stock with respect to which Mr. Manchak is willing to forfeit
his option.
THE INFORMATION SET FORTH ABOVE WITH RESPECT TO THE SECOND AMENDMENT
SUMMARIZES AND RESTATES CERTAIN TERMS AND PROVISIONS IN THE SECOND AMENDMENT.
THE COMPANY BELIEVES THAT SUCH SUMMARY CONTAINS A FAIR STATEMENT OF SUCH
DOCUMENT, HOWEVER, THE SUMMARY DOES NOT PURPORT TO BE COMPLETE AND IS
QUALIFIED BY REFERENCE TO THE SECOND AMENDMENT TO SETTLEMENT AGREEMENT WHICH
WAS FILED AS AN EXHIBIT TO THE COMPANY'S FORM 8-K DATED JULY 18, 1997.
The other debt of the Company includes the following: (i) an interest
bearing short-term note payable to a bank with an outstanding balance of
$3,330 that matures in June, 1997; (ii) an interest bearing short-term note
payable to its former legal counsel who represented the Company in the alleged
patent infringement lawsuit with an outstanding balance of $25,000 that
matures in December, 1997; (iii) one interest bearing long-term note, payable
to the Partnership, bearing interest at 8.25%, with a outstanding balance of
$49,651 that matures at January 1, 1999.
Effective June 30, 1997, the Company issued 136,500 shares of
unregistered common stock to four individuals in exchange for eliminating
$409,500 in debt. This transaction is reflected in the balance sheet of the
Company as of June 30, 1997. This transaction was reported in the Form 8-K filed
by the Company on July 18, 1997.
-10-
<PAGE> 11
The Company incurred costs through the second quarter of 1997 for
engineering work for a privately operated facility to be constructed in
Honolulu, Hawaii. In February, 1997, the Company made a formal request with
the City of Honolulu to reimburse all costs incurred to date, plus incidental
costs. On July 15, 1997, the Company signed Contract Change Order No. 1 with
the City of Honolulu to reimburse the Company "non-transferable" costs of
$200,000 by July 30, 1997 and $250,000 by July 15, 1998. An additional
$299,651 in "transferable" costs will be included in a new operating contract
fee structure with the City. The Company has received the $200,000 due July
30, 1997. This transaction was reported in the Form 8-K filed by the Company on
July 18, 1997.
In February, 1997, the Company obtained a working capital line of
credit of $100,000. Borrowings against the line bear interest at prime plus
1.75%, and are collateralized by accounts receivable, inventories and
equipment, and assignment of the wastewater treatment contract with the City
of Toledo, Ohio, and are due on demand. The balance owed on the line of credit
is $87,500 at June 30, 1997.
The Company believes that its working capital together with the line
of credit and reduction of debt through the delivery of unregistered shares of
stock to creditors, will provide sufficient cash to meet the Company's cash
requirements through 1997.
The Company cautions that words used in this document such as
"expects", "anticipates", "believes" and "may" as well as similar words and
expressions used herein identify and refer to statements describing events to
occur in the future. These forward-looking statements and the matters to which
they refer are subject to considerable uncertainty that may cause actual
results to be materially different from those described herein.
PART II - OTHER INFORMATION
Item 5. Other Information.
(a) None.
Item 6. Exhibits and Reports on Form 8-K
(a) Exhibits:
27 Financial Data Schedule
99 Press release dated August 12, 1997
(b) One report on Form 8-K was filed on July 18, 1997.
-11-
<PAGE> 12
N-VIRO INTERNATIONAL CORPORATION
Signatures
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
N-VIRO INTERNATIONAL CORPORATION
Date: August 14, 1997 /S/J. Patrick Nicholson
------------------- --------------------------------
J. Patrick Nicholson
Chairman, President and Chief Executive Officer
(Principal Executive Officer)
Date: August 14, 1997 /S/James K. McHugh
------------------- --------------------------------
James K. McHugh
Chief Financial Officer
(Principal Financial & Accounting Officer)
-12-
<TABLE> <S> <C>
<ARTICLE> 5
<CIK> 0000904896
<NAME> N-VIRO INTERNATIONAL
<S> <C>
<PERIOD-TYPE> 6-MOS
<FISCAL-YEAR-END> DEC-31-1997
<PERIOD-START> JAN-01-1997
<PERIOD-END> JUN-30-1997
<CASH> 79,072
<SECURITIES> 1,401
<RECEIVABLES> 1,107,166
<ALLOWANCES> 0
<INVENTORY> 0
<CURRENT-ASSETS> 2,394,134
<PP&E> 0
<DEPRECIATION> 0
<TOTAL-ASSETS> 4,354,567
<CURRENT-LIABILITIES> 2,081,327
<BONDS> 0
<COMMON> 22,308
0
0
<OTHER-SE> 0
<TOTAL-LIABILITY-AND-EQUITY> 4,354,567
<SALES> 0
<TOTAL-REVENUES> 2,150,159
<CGS> 0
<TOTAL-COSTS> 915,914
<OTHER-EXPENSES> 0
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 0
<INCOME-PRETAX> 373,434
<INCOME-TAX> 0
<INCOME-CONTINUING> 0
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> 373,434
<EPS-PRIMARY> 0.18
<EPS-DILUTED> 0
</TABLE>
<PAGE> 1
EXHIBIT 99
NEWS RELEASE FOR IMMEDIATE RELEASE
For More Information Contact:
J. Patrick Nicholson
Chief Executive Officer
or
James K. McHugh
Chief Financial Officer
(419) 535-6374
PROFITS UP AT N-VIRO
SECOND QUARTER AND YEAR-TO-DATE 1997
Toledo, Ohio, August 12, 1997 -- N-Viro International Corporation
[NASDAQ-NVIC] announced today that second quarter 1997 profits were $210,000,
or $.10 per share, an increase of $178,000 from the same period in 1996.
Revenues were $1.08 million, up 9 percent from 1996. For the year-to-date, net
profit has increased to $373,000, or $.18 per share, up 174 percent from 1996,
while revenues were $2.15 million, up 10 percent from 1996.
For both comparative periods, the increases in net profits are principally due
to the revenue increases and substantial reductions in general and
administrative expenses. The higher revenues derive from additional license
sales.
During the second quarter of 1997, agreements were reached to exchange debt
for common stock *, effectively increasing the liquidity of the Company by
over $400,000. These agreements, along with the net profits for the quarter,
helped boost the current ratio (current assets in excess of current
liabilities) from 0.92-to-1 at March 31, 1997, to over 1.15-to-1 at June 30,
1997, a 25 percent increase.
- 30 -
* Form 8-K filed with the Securities and Exchange Commission, July 18, 1997.
